European Liver Patients' Association

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
>
Registration as it was on 29 Nov 2022
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

300,000€ - 399,999€

Financial year: Jan 2021 - Dec 2021

Lobbyists (Full time equivalent)

6.75 Fte (9)

Lobbyists with EP accreditation

4

High-level Commission meetings

4

Lobbying Costs over the years

  • Info

    European Liver Patients' Association   (ELPA)

    EU Transparency Register

    89292219623-93 First registered on 13 Sep 2012

    Goals / Remit

    ELPA’s aim is to promote the interests of people with liver disease and in particular: to highlight the size of the problem; to promote awareness and prevention; to address the low profile of liver disease as compared to other areas of medicine such as heart disease; to share experience of successful initiatives; to work with professional bodies such as EASL and with the EU to ensure that treatment and care are harmonised across Europe to the highest standards. Our Mandate:ELPA emerged from a desire amongst European liver patient groups to share their experiences of the often very different approaches adopted in different countries. In June 2004, 13 patient groups from 10 European and Mediterranean Basin countries met to create the association. ELPA was formally launched in Paris on April 14th 2005 during the annual conference of the European Association for the Study of the Liver (EASL) and now has 32 members from 25 countries. Our ultimate goal is a world without liver diseases.

    Main EU files targeted

    All aspects related to health, cancer, health statistics, research, development for health, cross-border healthcare, access to healthcare, new digital aspects of health, data privacy issues, clinical and pharmaceutical development.

    Address

    Head Office
    Schuman Roundabout 2-4, Level 6, 1040 Brussels, Belgium
    Brussels 1040
    BELGIUM
    EU Office
    Schuman Roundabout 2-4, Level 6, 1040 Brussels, Belgium
    Brussels 1040
    BELGIUM

    Website

  • People

    Total lobbyists declared

    9

    Employment timeLobbyists
    100%4
    75%2
    50%2
    25%1

    Lobbyists (Full time equivalent)

    6.75

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    4 accreditations were / are live (in bold) for the selected state of 28 Jan 2023

    Name Start date End Date
    Ms Beatrice CREDI 12 Jan 2023 11 Jan 2024
    Mr Milan MISHKOVIKJ 12 Jan 2023 11 Jan 2024
    Mr Marko KORENJAK 12 Jan 2023 11 Jan 2024
    Ms Veronika VŠETIČKOVA 07 Oct 2022 06 Oct 2023
    Mr Milan MISHKOVIKJ 18 Jan 2022 12 Jan 2023
    Mr Marko KORENJAK 18 Jan 2022 12 Jan 2023
    Ms Beatrice CREDI 21 Dec 2021 21 Dec 2022
    Mr Milan MISHKOVIKJ 05 Jan 2021 05 Jan 2022
    Ms Veronika VSETICKOVA 05 Jan 2021 05 Jan 2022
    Mr Marko KORENJAK 05 Jan 2021 05 Jan 2022
    Mr Milan MISHKOVIKJ 01 Nov 2019 31 Oct 2020
    Mr Marko KORENJAK 08 Oct 2019 08 Oct 2020

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    EMA PCWP
    https://www.ema.europa.eu/en/partners-networks/patients-consumers/eligible-patients-consumers-organisations

    EMA PRAC
    https://www.ema.europa.eu/en/committees/pharmacovigilance-risk-assessment-committee-prac

    EASL Policy & Public Health Committee
    https://easl.eu/easl/leadership-and-governance/policy-public-health-advocacy-committee/#:~:text=The%20mission%20of%20the%20Policy,public%20affairs%20goals%20and%20objectives.

    ECDC Advisory Forum
    https://www.ecdc.europa.eu/en/about-ecdc/who-we-are/governance/advisory-forum/observers

    ECDC working group on monitoring hepatitis B and C in the EU
    https://www.ecdc.europa.eu/sites/default/files/documents/hepatitis-B-C-monitoring-responses-hepatitis-B-C-epidemics-EU-EEA-Member-States-2019.pdf

    WHO EURO Collaborating Committee on TB, HIV, and viral hepatitis
    https://www.who.int/europe/groups/regional-collaborating-committee-on-accelerated-response-to-tuberculosis-hiv-and-viral-hepatitis-(rcc-thv)/about

    HERA Civil Society Forum
    https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera/advisory-forum_en#civil-society-forum

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2021 - Dec 2021

    Lobbying costs for closed financial year

    300,000€ - 399,999€

    Major contributions in closed year

    TypeNameAmount
    Grant EU Commission 41,000€

    Major contributions in current year

    TypeNameAmount
    Grant EU Commission 72,000€

    Intermediaries for closed year

    NameAmount
    moore stephens, belgium 0€ - 10,000€

    Intermediaries for current year

    Name
    moore stephens, belgium

    Closed year Costs

    300,000€ - 399,999€

    Other financial info

    EU grants were received because we are in Consortium Partners in EU Horizon2020 projects.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    Cancer

    Other activities

    Advocacy for improving European activities in the field of liver diseases.
    Advocacy in the field of alcohol policy.
    Advocacy in the field of HCC.
    Advocacy in the field of public health, i.e. health determinants,viral hepatitis.

  • Meetings

    Meetings

    4 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

Download this datacard